Clinical Research
Copyright ©The Author(s) 2005.
World J Gastroenterol. Oct 14, 2005; 11(38): 5988-5992
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.5988
Table 1 LR+ of low serum level of fasting G-17 in whole study population
G-17fast pmol/LBarrettnControlsnLR+(95%CI)
<0.57213.5 (1.39.3)
<19313.0 (1.37.3)
<1.513482.8 (1.36.1)
<215662.4 (1.14.9)
<317892.0 (1.04.0)
<5181231.5 (0.83.0)
All191991
Table 2 LR+ of low serum level of fasting G-17 in patients and controls (males and females) with normal and healthy gastric mucosae (histology)
G-17fastpmol/LBarrettnControlsnLR+(95%CI)
<0.5675.6 (1.719)
<17123.8 (1.311)
<1.510252.6 (1.16.5)
<212421.9 (0.84.3)
<314611.5 (0.73.3)
<515791.2 (0.62.7)
All161051
Table 3 LR+ of low serum level of fasting G-17 in patients and controls with healthy gastric mucosa, no H. pylori antibodies and serum pepsinogen I 50 mg/L
G-17fast pmol/LBarrettnControlsnLR+(95%CI)
<0.56133.1 (1.09.4)
<18192.8 (1.17.6)
<1.511342.2 (0.95.1)
<213491.8 (0.84.0)
<315651.6 (0.73.4)
<515811.3 (0.62.7)
All161081